Arfolitixorin

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameArfolitixorin
Drug Alias Name亚甲基四氢叶酸Methylenetetrahydrofolate - IsofolMTHF - IsofolArfolitixorinmethyleneTHF +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThymidylate synthase inhibitorsFolate receptor alpha antagonistsFolate receptor beta antagonists
TargetsThymidylate synthaseFolate receptor alphaFolate receptor beta
Therapy Area/IndicationsRectal NeoplasmsColonic NeoplasmsColorectal Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaCanadaUnited States +[15] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesIsofol Medical Ab
China Registration ClassN/A

Develop Information

Active CompaniesSolasia PharmaPaladin Labs IncIsofol Medical Ab
Inactive CompaniesN/A
Active IndicationsRectal NeoplasmsColorectal Neoplasms
Inactive IndicationsColonic NeoplasmsOsteosarcoma

Other Information

ATC CodeN/A
Related LinksKEGG